OKT3 and H57-597: From Discovery, to Commercialization, to the Clinic

Kristin A. Hogquist

doi:10.4049/jimmunol.1601599

Main menu

Home
Articles
COVID-19/SARS/MERS Articles
Info
Editors
Submit
Subscribe
More

Other Publications
- American Association of Immunologists
- ImmunoHorizons

User menu

Search

Search for this keyword

Advanced search

Other Publications
- American Association of Immunologists
- ImmunoHorizons

Search for this keyword

Advanced Search

Home
Articles
COVID-19/SARS/MERS Articles
Info
Editors
Submit
Subscribe
More

Follow The Journal of Immunology on Twitter
Follow The Journal of Immunology on RSS

OKT3 and H57-597: From Discovery, to Commercialization, to the Clinic

Kristin A. Hogquist

J Immunol November 1, 2016, 197 (9) 3429-3430; DOI: https://doi.org/10.4049/jimmunol.1601599

Kristin A. Hogquist

Center for Immunology, University of Minnesota, Minneapolis, MN 55455

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Additional Files

Download figure
Open in new tab
Download powerpoint

Additional Files

Figures

ImmunoCast

November 1 2016 Pillars of Immunology (MP3, 8.4 Mb, 00:06:25)
Dr. Kristen Hogquist discusses two of the most highly cited papers in the 100-year history of The Journal of Immunology, papers which describe the function or characterization of monoclonal antibodies to the human and mouse T cell receptors.

PreviousNext

In this issue

The Journal of Immunology

Vol. 197, Issue 9

1 Nov 2016

Table of Contents
Table of Contents (PDF)
About the Cover
Advertising (PDF)
Back Matter (PDF)
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following OKT3 and H57-597: From Discovery, to Commercialization, to the Clinic

Message Subject (Your Name) has forwarded a page to you from The Journal of Immunology

Message Body (Your Name) thought you would like to see this page from the The Journal of Immunology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OKT3 and H57-597: From Discovery, to Commercialization, to the Clinic